Global Viral Vectors and Plasmid DNA Manufacturing Competitive Landscape Professional Research Report 2024

Research Summary

Viral vectors and plasmid DNA manufacturing are integral processes in the production of gene therapy and vaccines. Viral vectors are modified viruses engineered to deliver therapeutic genes into target cells, while plasmid DNA serves as a vehicle for carrying genetic material into cells. The manufacturing process involves multiple steps, including vector or plasmid design, cell culture, transfection, purification, and quality control. For viral vectors, the chosen viral backbone is modified to remove its ability to replicate and cause disease, while retaining its ability to efficiently deliver genetic material into host cells. Plasmid DNA is produced by cloning the target gene into a bacterial plasmid, followed by large-scale bacterial fermentation and purification. Both viral vectors and plasmid DNA undergo rigorous quality control testing to ensure purity, potency, and safety before being used in clinical applications. These manufacturing processes require adherence to strict regulatory guidelines to ensure the safety and efficacy of gene therapy and vaccine products. As the field of gene therapy continues to advance, optimized manufacturing techniques are crucial to meet the growing demand for these innovative treatments.

According to DIResearch's in-depth investigation and research, the global Viral Vectors and Plasmid DNA Manufacturing market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Viral Vectors and Plasmid DNA Manufacturing include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Lonza, Aldevron, Eurogentec, Cell and Gene Therapy Catapult, Biovian, Thermo Fisher Scientific (Brammer Bio), VGXI, PlasmidFactory etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Viral Vectors and Plasmid DNA Manufacturing. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Viral Vectors and Plasmid DNA Manufacturing market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Viral Vectors and Plasmid DNA Manufacturing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Viral Vectors and Plasmid DNA Manufacturing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Viral Vectors and Plasmid DNA Manufacturing Include:

BioReliance

Cobra Biologics

Oxford BioMedica

UniQure

FinVector

MolMed

MassBiologics

Richter-Helm

FUJIFILM Diosynth Biotechnologies

Lonza

Aldevron

Eurogentec

Cell and Gene Therapy Catapult

Biovian

Thermo Fisher Scientific (Brammer Bio)

VGXI

PlasmidFactory

Viral Vectors and Plasmid DNA Manufacturing Product Segment Include:

Plasmid DNA

Viral Vectors

Viral Vectors and Plasmid DNA Manufacturing Product Application Include:

Cancers

Inherited Disorders

Viral Infections

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Viral Vectors and Plasmid DNA Manufacturing Industry PESTEL Analysis

Chapter 3: Global Viral Vectors and Plasmid DNA Manufacturing Industry Porter's Five Forces Analysis

Chapter 4: Global Viral Vectors and Plasmid DNA Manufacturing Major Regional Market Size and Forecast Analysis

Chapter 5: Global Viral Vectors and Plasmid DNA Manufacturing Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Viral Vectors and Plasmid DNA Manufacturing Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Viral Vectors and Plasmid DNA Manufacturing Market Overview

1.1 Product Definition and Statistical Scope

1.2 Viral Vectors and Plasmid DNA Manufacturing Product by Type

1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Plasmid DNA

1.2.3 Viral Vectors

1.3 Viral Vectors and Plasmid DNA Manufacturing Product by Application

1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Cancers

1.3.3 Inherited Disorders

1.3.4 Viral Infections

1.3.5 Others

1.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Revenue Analysis (2019-2030)

1.5 Viral Vectors and Plasmid DNA Manufacturing Market Development Status and Trends

1.5.1 Viral Vectors and Plasmid DNA Manufacturing Industry Development Status Analysis

1.5.2 Viral Vectors and Plasmid DNA Manufacturing Industry Development Trends Analysis

2 Viral Vectors and Plasmid DNA Manufacturing Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Viral Vectors and Plasmid DNA Manufacturing Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Regions

4.1 Viral Vectors and Plasmid DNA Manufacturing Overall Market: 2023 VS 2024 VS 2030

4.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Region (2019-2024)

4.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Region (2025-2030)

5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type and Application

5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

6 North America

6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

6.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

6.5 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

7.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

7.5 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

8.4 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

9.4 APAC (excl. China) Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

9.5 APAC (excl. China) Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

10.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

10.5 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type

11.4 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application

11.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Revenue by Key Manufacturers (2020-2024)

12.2 Viral Vectors and Plasmid DNA Manufacturing Competitive Landscape Analysis and Market Dynamic

12.2.1 Viral Vectors and Plasmid DNA Manufacturing Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 BioReliance

13.1.1 BioReliance Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Cobra Biologics

13.2.1 Cobra Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Oxford BioMedica

13.3.1 Oxford BioMedica Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 UniQure

13.4.1 UniQure Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 FinVector

13.5.1 FinVector Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 MolMed

13.6.1 MolMed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 MassBiologics

13.7.1 MassBiologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Richter-Helm

13.8.1 Richter-Helm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 FUJIFILM Diosynth Biotechnologies

13.9.1 FUJIFILM Diosynth Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Lonza

13.10.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Aldevron

13.11.1 Aldevron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Eurogentec

13.12.1 Eurogentec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Cell and Gene Therapy Catapult

13.13.1 Cell and Gene Therapy Catapult Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Biovian

13.14.1 Biovian Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Thermo Fisher Scientific (Brammer Bio)

13.15.1 Thermo Fisher Scientific (Brammer Bio) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 VGXI

13.16.1 VGXI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 PlasmidFactory

13.17.1 PlasmidFactory Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Portfolio

13.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Viral Vectors and Plasmid DNA Manufacturing Industry Chain Analysis

14.2 Viral Vectors and Plasmid DNA Manufacturing Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Viral Vectors and Plasmid DNA Manufacturing Typical Downstream Customers

14.4 Viral Vectors and Plasmid DNA Manufacturing Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support